NCT06170125View on ClinicalTrials.gov

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

February 28, 2026

Conditions
COPD
Interventions
OTHER

Tiotropium treated patients

Patients who are not satisfied with their COPD treatment and will be on additional tiotropium scheme.

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY